Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.
BACKGROUND: More than 1 million tuberculosis (TB) patients are receiving directly observed treatment strategy (DOTS) therapy in China every year. As to the profile of adverse drug reactions (ADRs) due to DOTS therapy, no consensus has been reached. There is no report regarding ADRs due to DOTS thera...
Main Authors: | Xiaozhen Lv, Shaowen Tang, Yinyin Xia, Xiaomeng Wang, Yanli Yuan, Daiyu Hu, Feiying Liu, Shanshan Wu, Yuan Zhang, Zhirong Yang, Dehua Tu, Yixin Chen, Peiyuan Deng, Yu Ma, Ru Chen, Siyan Zhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3672195?pdf=render |
Similar Items
-
Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China
by: Wu Shanshan, et al.
Published: (2012-06-01) -
Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort.
by: Shaowen Tang, et al.
Published: (2013-01-01) -
NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population
by: Xiaozhen Lv, et al.
Published: (2012-09-01) -
Analysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study.
by: Jing Wang, et al.
Published: (2015-01-01) -
Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.
by: Penghui Shang, et al.
Published: (2011-01-01)